VC Fund Dossiers

360 Capital is one of Europe's most successful old-school VC shops that actually delivers results—their Preligens exit to Safran for €220M in 2024 and backing Exotec to become France's first industrial unicorn proves they know how to pick winners and get liquidity. Founded in 1997, they've survived multiple cycles and have the conviction to back deep tech when others chase software. Fausto Boni is a genuine operator with McKinsey pedigree who sits on boards and gets his hands dirty. The dual Paris-Milan setup gives them unique access to Southern European talent that coastal VCs miss. Their 71% seed to Series A conversion rate (92% including exits) is exceptional. Watch for their climate tech focus with the new €140M 360 LIFE II fund—they're betting big on energy transition when others just talk about it.

Act met Barry Napier "over a decade ago" and made "the largest seed investment we possibly could" - this is a fund that bets big early and doubles down on winners. They explicitly say "We have never been the loudest venture firm" and "don't want to add to the noise of VCs making it about them." Strong exit track record including SilverCloud Health (acquired by Amwell), Decawave (acquired by Qorvo), and 34 total portfolio exits. Their strategy is clear: "find the best company builders at the earliest stages and continue to back them again and again." This isn't a spray-and-pray fund - they're conviction-driven, founder-focused, and have the dry powder (€140M Fund VI) to support you through multiple rounds.

Adobe Ventures is basically Adobe's corporate development arm disguised as a VC fund - they're scouting acquisition targets, not building a traditional venture portfolio. If your startup fits their ecosystem, you get incredible platform access and potential acquirer interest, but don't expect them to lead rounds or fight for you against other acquirers. Scott Belsky brings real credibility and founder empathy, but remember that Adobe's strategic interests will always trump pure financial returns. They're great for martech and creative tool companies that want Adobe partnership, but probably not your best bet if you're building something completely orthogonal to their business.

Aglae is essentially Bernard Arnault's tech investment arm masquerading as a standalone VC - which is both their superpower and their Achilles heel. They have stupid money (LVMH backing means they can write big checks without blinking), phenomenal brand access through the luxury ecosystem, and a track record that includes some absolute bangers. But here's the catch: they're not really building a venture brand, they're executing family office investment strategy. The team is solid but small, and while Antoine brings decent deal flow, this isn't Sequoia-level pattern recognition. If you need growth capital and can benefit from luxury/premium brand connections, they're golden. If you want hands-on operational support or deep sector expertise, look elsewhere.

Alliance is the rare Nordic VC that actually walks the walk on 'founder-friendly' instead of just talking about it. From your very first meeting, you're speaking directly with a partner — no junior associates wasting your time. Every partner has equal voting power and they make decisions by majority, but they value passionate conviction when a partner pounds the table for a deal. The sustainability angle isn't just marketing fluff — they genuinely believe it drives long-term value creation. Their exit rate is 19 percentage points higher than average VCs, which suggests they know how to pick and support winners. With offices across the Nordics and strong ties to Silicon Valley, they're well-positioned to help ambitious founders scale globally.

This is Amazon's strategic arm masquerading as a VC fund - they're shopping for acquisition targets and ecosystem partners, not just financial returns. If your startup has Amazon synergies, they can be incredibly valuable with distribution, AWS credits, and Alexa integration support. But founders should know they're essentially auditing for Amazon - expect deep technical due diligence and be prepared for acquisition pressure if you succeed. The team knows voice tech cold and has real operational chops, but this isn't independent capital. They move slowly on decisions and everything gets filtered through Amazon's broader strategic priorities.

AppWorks has quietly become one of Asia's most successful early-stage platforms by mastering two things most VCs struggle with: geographic focus and community building. Their "ABS" thesis (AI, Blockchain, Southeast Asia) isn't just marketing speak — they've delivered with unicorns like Dapper Labs and Animoca Brands. Jamie Lin runs a tight ship with strong conviction on web3 before it was cool, and Jessica Liu knows SEA markets better than most Silicon Valley partners know their own backyard. The accelerator program creates a genuine founder community that actually helps portfolio companies work together. However, their Taiwan-centric team may struggle with nuanced market entry in diverse SEA countries, and their heavy blockchain bet could look risky if crypto winter persists. They're operator-friendly and move fast on decisions, but expect them to push hard on regional expansion plans that might not fit your timeline.

Armilar is the real deal - they've backed three unicorns (OutSystems, Feedzai, Sword Health) and have genuine deep-tech credibility spanning 25+ years. Their track record of generating returns is grounded on backing founders throughout their journey, not just writing checks. However, they work on 16 percentage points less than the average amount of lead investments, meaning they're selective but might not always lead your round. The fact they successfully raised €120M in 2025's brutal fundraising environment speaks volumes about LP confidence in their returns. The senior team has been working together for a decade with 60+ years of cumulative VC experience - this isn't a new fund with untested dynamics.

Axon is that rare breed - a publicly traded VC (BME: APG) with €685 million AUM that actually knows what they're doing. With 1 unicorn (Forto), 7 IPOs, and 11 acquisitions in their portfolio, they've got the track record to back up the hype. The dual consulting-investment model is either genius or a distraction - it gives them deep sector insights but might split focus. Francisco Velazquez landing on the EU Innovation Council board shows they have serious Brussels connections, which matters for regulatory-heavy sectors. They're heavy on Spain/Southern Europe but expanding globally, so perfect if you're a Spanish startup needing local expertise and international ambitions. The climate tech push feels authentic given their track record, not just trend-chasing.

This is the Bertelsmann money machine with Chinese characteristics - Annabelle Long built one of China's most successful VC franchises from scratch and it shows. Since 2008, she's led the team to achieve more than 18 IPOs and more than 40 unicorns, including Linklogis, Lexin, NetEase Cloud Music, SF Intra-City, Stori, Keep, PingCAP, Mobike, and others. The Bertelsmann backing gives them patient capital and global network access that pure financial VCs can't match. They're genuinely good at spotting Chinese companies that can scale globally - see Stori becoming Mexico's newest unicorn. Long is old-school media savvy (started as a TV anchor) which translates to strong founder relationships and board presence. The downside? They're betting heavily on China-to-global expansion at a time when geopolitical headwinds are only getting stronger, and their sweet spot might be getting squeezed by rising US-China tensions.

Bayern Kapital operates as a co-investor alongside private investors, adhering to the pari-passu principle, and typically holds minority stakes. We invest according to the pari-passu principle. In the case of a financing round, this means that all parties involved are treated equally and must invest the same amount of capital as Bayern Kapital. This is both their strength and potential limitation - they're patient, government-backed capital that won't push for quick exits, but they require private lead investors to move. With 3 unicorns (IQM, Quantum Systems, EGYM) and strong exits like MorphoSys, they clearly pick winners, but their bureaucratic structure means slower decisions than pure private funds. Their 8-10 year investment horizons and €700M+ AUM make them ideal for deep tech that needs patient capital, but expect more process and committees than your typical VC.

This is KBank doing corporate VC right – they actually understand the synergy game. They're laser-focused on startups that can integrate with Thailand's largest bank, not just spray-and-pray investing. Thanapong has serious street cred and real exits under his belt, which matters more than most founders realize. The sustainability angle through their Impact Fund isn't just ESG theater – they're putting real money ($17M+ deployed) behind climate tech. Four unicorns in their portfolio including Grab and NIUM proves they can spot winners early. However, being a corporate VC means they move slower than pure-play funds, and you'll definitely be expected to play nice with KBank's strategic interests. Joy deLeon adds solid finance chops and international perspective, but the team is still relatively small for a $255M fund.

Big Pi is the real deal in the Greek/diaspora space - they're not just tourist money but serious operators with legit exits under their belt (Accusonus to Meta for €70-100M). The team brings actual entrepreneurial chops: Marco built Upstream to €230M revenue, Nick was at Prime Ventures doing serious European deals, and Alex literally helped create the Python data science stack. They require portfolio companies to maintain substantial Greek operations, which is both a feature (cheap talent, government support) and potential bug (geographic constraint). Their "tech-first" mandate with IP requirements means they actually understand what defensible tech looks like, unlike funds that chase flashy B2C plays.

This is the corporate VC arm of a massive government consulting firm, which is both their superpower and their limitation. They're incredibly well-connected in federal circles and can open doors that traditional VCs simply can't touch. Portfolio companies get access to Booz Allen's 29,000+ employees and deep government relationships. However, they're not your typical Silicon Valley fund - they think in government timelines, move more cautiously, and their investment committee includes corporate stakeholders who may not understand startup urgency. Great if you're building dual-use tech and need government validation, but don't expect the same hustle mentality as pure-play VCs.

Bosch Ventures is the real deal if you need an industrial giant's resources behind you, but don't expect typical VC speed or risk appetite. They move deliberately and want clear strategic value for Bosch, not just financial returns. The upside is massive - access to Bosch's 400,000+ employees, manufacturing expertise, and global customer base can accelerate B2B startups like crazy. The downside is corporate venture bureaucracy and they'll push hard for commercial partnerships that may not always align with your broader strategy. Great for hardware and deep tech companies that need patient capital and industrial know-how.

Bright Pixel is basically Sonae's corporate venture arm with €250M deployed across 60+ companies, which sounds impressive until you realize they're essentially a retail conglomerate trying to stay relevant in tech. The good news: they have four unicorns including Feedzai and Arctic Wolf, proving they can spot winners. The reality check: as a corporate VC, they're always going to prioritize strategic value over pure financial returns, which means potential acqui-hire pressure down the road. Their team seems genuinely knowledgeable about cybersecurity and retail tech, but founders should expect longer decision cycles and more stakeholder management than with pure-play VCs.

Buoyant is one of the more credible climate-focused funds that actually understands both the science and the business side. Amy Francetic has real operational chops and won't blow smoke up your ass about market timing or regulatory tailwinds. They're not writing massive checks, but they're genuinely helpful post-investment and have solid networks in the climate ecosystem. The team is small but experienced, and they tend to move quickly on deals they like. Just don't expect them to lead your Series B — they're focused on early-stage and will need you to have a clear path to follow-on funding.

This is Spain's establishment VC - they're the corporate venture arm of CriteriaCaixa, which manages over €25 billion and is backed by la Caixa Foundation. They've been around since 2007 and have made 300+ investments, so they know what they're doing, but they're also exactly what you'd expect from a big Spanish bank's VC arm. The good news: they have serious capital staying power, they actually stick around for follow-on rounds, and they exit 20% more often than average. The reality check: they're not exactly known for being the fastest movers or most founder-friendly when it comes to terms. New CEO Jordi Ros comes from 20 years of traditional corporate finance, not startup-land.

CIC has genuinely unique deal flow through their exclusive Cambridge University relationship - this isn't marketing fluff, they literally have privileged access to the best IP coming out of one of the world's top research universities. Their track record speaks for itself: Bicycle Therapeutics IPO on NASDAQ, CMR Surgical unicorn, Gyroscope sold to Novartis for $1.5B, plus solid exits like Inivata ($390M) and PetMedix ($285M). Williamson brings serious credibility - 20 years US VC experience and co-chaired the UK government's university spinout review, so he knows the ecosystem inside out. Their Entrepreneur in Residence program is actually working - they're co-founding companies like Immutrin (just raised £65M from Frazier Life Sciences) by pairing seasoned operators with Cambridge academics. The downside? You're essentially betting on Cambridge staying relevant in deep tech, and they're very UK-focused if you want Silicon Valley-style growth.

Capital One Ventures is the corporate VC arm that actually behaves like a corporate VC arm - meaning they're laser-focused on strategic value, not just financial returns. They're solid partners if your startup could genuinely benefit from Capital One's customer base, data, or banking infrastructure. But don't expect them to lead rounds or move quickly - they're methodical to a fault and everything gets filtered through 'how does this help Capital One?' The upside is real operational support and potential acquisition interest. The downside is they'll ghost you if the strategic fit isn't obvious, and their investment committee moves at big-bank speed.

Cathay Innovation is genuinely useful if you're serious about Asia expansion, but don't expect them to be your primary US growth driver. Their China network is real and valuable - they've actually helped portfolio companies navigate regulatory complexity and find local partnerships that matter. The partners know their stuff operationally, but they're not the flashiest brand name for Silicon Valley credibility. They write reasonable check sizes for European growth stage but can be slow to decision-making due to cross-border coordination. If Asia is core to your strategy, they're worth the conversation. If it's just nice-to-have, there are faster, more focused options.

CCV is the rare fund that actually delivers on its unicorn promises — 35% unicorn formation rate in first decade is legit eye-popping. Wei Zhou's KPCB pedigree runs deep and founders seem to genuinely respect his operator-first approach rather than typical VC interrogation style. The Ximalaya exit to Tencent for $2.4B shows they can navigate complex China market dynamics and actually get liquidity when others can't. But here's the thing — they're effectively a one-man show built around Wei's personal brand and network. CCV is the A-round leading investor in 80% of its investments which means they're conviction-driven, not spray-and-pray. The 'go global' messaging feels forced given their China-heavy portfolio, and you're basically betting on Wei's continued Midas touch in an increasingly challenging cross-border investment environment.

CDP is Italy's €4 billion sovereign wealth fund playing venture capitalist - which means you get the benefits of patient capital and government backing, but also all the bureaucracy that comes with it. They have an initial €1 billion to deploy and are making 40-50 investments per year, so they're not exactly selective. The real power here is Francesca Bria - she's the rare government appointee who actually gets technology and has street cred from transforming Barcelona's smart city approach. Under Resmini they grew from €230M to €4B AUM in 3 years, which is impressive scaling but raises questions about quality control. They're essentially the Italian government's attempt to bootstrap a venture ecosystem, so expect slower decision-making but also less pressure for quick exits since they're playing the long game for Italy's economic development.

CGC consistently wins entrepreneur popularity awards, with Haiyan Wu specifically recognized for being founder-friendly. They manage $1.2B across RMB and USD funds since 2006 and have genuine sector expertise rather than generalist spray-and-pray. Wu Haiyan's recent comments about missing DeepSeek but leading SiliconFlow's round show they're still hunting for AI alpha. They claim to 'proactively assist with talent acquisition and go-to-market strategy' - and their enterprise software wins suggest they actually deliver on operational support. The risk? Their thesis that 'consumer opportunities are saturating' might be early and their bet on enterprise/B2B could face headwinds in China's slowing economy.

Cisco Investments is the classic corporate VC - they're shopping for their parent company, not optimizing for pure financial returns. The good news: they have deep pockets, patient capital, and can open massive enterprise doors. The reality check: you're essentially auditioning for an acquisition, and if Cisco decides to build instead of buy, you might find yourself competing with your investor. They're professional and well-connected, but don't expect them to fight for your independence if Cisco comes calling. Best case scenario: you become the next Duo Security (sold for $2.35B). Worst case: you get caught in Cisco's strategic shifts and left hanging.

Citi Ventures is corporate VC in its purest form — they want strategic value first, financial returns second. If you're building something that could integrate with Citi's massive customer base or banking infrastructure, they're golden. But if you're looking for pure venture capital behavior, you'll be frustrated. Decisions move at bank speed, not startup speed. They're great at opening doors within Citi and providing regulatory guidance, but don't expect them to lead rounds or move fast. The team is competent but constrained by corporate bureaucracy.

Comcast Ventures is the definition of strategic capital done right - they actually deliver on the corporate partnership promises that most strategic VCs just talk about. If your product can integrate with NBCUniversal content, Xfinity services, or Comcast's advertising stack, they'll open doors that pure financial VCs simply can't. The flip side is they're laser-focused on strategic fit, so don't waste their time if you can't articulate clear synergies. Their check sizes are meaningful ($5-25M range) and they move fast when they see strategic value, but they'll pass quickly if the corporate angle doesn't make sense.

Contrary is legitimately different from other VCs — they actually back founders from unexpected backgrounds and geographies, not just Stanford dropouts. Eric Tarczynski has real conviction and moves fast, but he's also known for being extremely hands-on to the point where some founders feel micromanaged. Their sourcing is genuinely impressive and they'll take meetings others won't, but expect intense diligence and strong opinions on strategy. They've had some real winners, but their portfolio construction can be scattered across stages and sectors.

Databricks Ventures is the classic corporate VC play - they invest in companies that make their core platform stickier and more valuable. The upside is real: they have deep technical credibility, massive enterprise relationships, and can provide incredible distribution channels if your product fits their ecosystem. The downside is equally real: this is strategic investing, not financial investing. If your roadmap diverges from what benefits Databricks, expect friction. They're also relatively new to the VC game, so don't expect the same institutional investing expertise you'd get from a dedicated fund. Best case scenario: you become a key part of the Databricks stack and ride their growth rocket. Worst case: you become a feature request.

DCM is a solid, no-nonsense shop that actually helps you scale internationally if that's your thing. They're particularly strong if you're building B2B software and want access to Asian markets - their network there is legit. Jason Krikorian is sharp on product strategy and won't sugarcoat feedback. The downside? They're not the flashiest name on your cap table, and their marketing game is pretty weak compared to peers. They tend to be methodical rather than aggressive, which is great for steady builders but might frustrate founders who want rapid-fire decision making.

DCVC is the rare fund that actually understands deep tech beyond the buzzwords — these guys can evaluate your algorithm and your go-to-market strategy with equal sophistication. They're genuinely helpful post-investment, especially if you're navigating complex enterprise sales cycles or regulatory approval processes. The downside? They have very high technical bars and can be slow to move if they're not immediately convinced of your computational moat. Don't pitch them unless you have serious IP or algorithmic differentiation — they'll smell BS from a mile away.

DTC claims 95th percentile returns performance compared to early-stage VC firms - that's either the real deal or excellent marketing. The corporate VC advantage here is real: they're connected to Dell's massive enterprise platform with Fortune 1000 customers, world-class technologists, and partnerships. Founders consistently praise their enterprise sales knowledge and ability to land large customers through Dell introductions in early days. No dedicated fund size gives them flexibility on check size and stage, they've invested $1.8B across 165 companies, make 15-16 new investments annually. The downside of corporate VC applies: they're ultimately strategic investors serving Dell's interests, not just financial returns, so expect them to push for partnerships and integrations that benefit the mothership.

Here's the thing - there's no 'Elevance Health Ventures' VC fund. You're looking at a $177B health insurance giant that deploys capital very differently than traditional VCs. They write massive checks for strategic acquisitions and partnerships (like their $4B primary care venture with PE firm Clayton Dubilier & Rice), not seed rounds for health tech startups. Their 'venture' activity is really corporate development on steroids - they buy established healthcare companies to vertically integrate their insurance business. If you're a startup founder looking for venture capital, this isn't your fund. But if you're a later-stage healthcare services company looking for a strategic acquirer with deep pockets and 119 million covered lives, now we're talking.

Each partner makes just one investment annually and the whole team works on every deal - this isn't marketing fluff, it's their actual model and they have zero partner turnover with sustained support throughout your journey. The founder testimonials are unusually specific and glowing, suggesting they actually deliver on the white-glove treatment. Eric Yuan calls them 'family' and says they were Zoom's first Silicon Valley institutional investor. However, their selectivity is real - only 5-7 deals per year means you're competing against the entire enterprise software universe for their attention. Co-founder Jason Green stepped back in 2021 after 30 years, so you're working with the next generation, though Gordon Ritter is still very active and made Forbes Midas List four times.

Emergence Capital is the definition of conviction-driven investing—they've mastered the art of going all-in on a tiny number of bets and hitting home runs. Their one-investment-per-partner-per-year model isn't marketing fluff; it's real, and founders feel the difference. The Zoom and Veeva wins created generational wealth and cemented their reputation as B2B SaaS kingmakers. What's impressive is their zero partner turnover culture and internal promotion track record—Jake Saper and Santi Subotovsky both worked their way up, creating genuine institutional knowledge. They're obsessed with AI-enabled services and 'deep collaboration' themes, sometimes to a fault—they can get thesis-heavy and miss opportunities outside their framework. Post-investment, they're genuinely helpful operators who understand enterprise sales motions and hiring, not just check-writers.

Entrée is what happens when actual operators build a VC fund - and it shows in their portfolio performance. With offices in Israel, UK, and the US, Entrée Capital has realized 30 exits and IPOs and its portfolio has 18 unicorns. Avi Eyal's track record speaks for itself: he's the guy who led monday.com from seed to $8B+ IPO and got Amazon to pay hundreds of millions for PillPack. Unlike many VCs who just write checks, this team actually helps founders build companies - they have operational DNA from being serial entrepreneurs themselves. The downside? They can be picky to the point of being almost arrogant about what constitutes "exceptional" founders, and their Israeli roots mean they have strong opinions about how things should be done.

This isn't your typical family office - it's Renaissance Technologies with a venture capital arm. Euclidean Capital serves as a family office of James Simons who is a hedge fund manager, mathematician, and founder of Renaissance Technologies. The stocks represent just a small part of Euclidean's portfolio - most are 'residuals' from VC investments they held onto after IPO. They're essentially doing quantitative venture capital before anyone called it that. The team is small but incredibly sophisticated - Chhabra pioneered goals-based wealth management and Miller has deep quant experience. They write big checks ($50M+ rounds) and focus on math-heavy sectors where their analytical edge matters most. Don't expect warm fuzzy founder support - this is clinical, data-driven capital.